Revenue and Losses - Revenue for the three months ended March 31, 2025, was 979,977,comparedto0 for the same period in 2024, indicating a significant increase[12] - Net loss for the three months ended March 31, 2025, was (11,495,947),comparedto(9,995,136) for the same period in 2024, representing an increase in losses[12] - For the nine months ended March 31, 2025, the company reported a net loss of 36.6million,comparedtoanetlossof29.1 million for the same period in 2024, indicating a 26% increase in losses year-over-year[21] - The company reported a net loss per share of (0.14)forthethreemonthsendedMarch31,2025,comparedto(0.19) for the same period in 2024[12] Expenses and Financial Performance - Gross loss for the three months ended March 31, 2025, was (2,689,960),whilethegrosslossfortheninemonthsendedMarch31,2025,was(8,003,944)[12] - Total operating expenses for the nine months ended March 31, 2025, were 26,245,059,comparedto25,433,780 for the same period in 2024, reflecting a slight increase[12] - The company incurred stock-based compensation expenses of 12.8millionfortheninemonthsendedMarch31,2025,comparedto12.3 million in the same period of 2024[21] - Stock-based compensation expense for the period reached 6,330,914,contributingtotheoverallfinancialperformance[15]AssetsandLiabilities−CashandcashequivalentsasofMarch31,2025,were2,849,257, down from 7,001,786asofJune30,2024[9]−Totalcurrentassetsincreasedto23,285,228 as of March 31, 2025, compared to 18,406,048asofJune30,2024[9]−Totalliabilitiesdecreasedto10,851,323 as of March 31, 2025, from 16,207,492asofJune30,2024[9]−Stockholders′equityincreasedto65,605,927 as of March 31, 2025, compared to 61,467,640asofJune30,2024[9]InventoryandProduction−AsofMarch31,2025,thetotalinventorywas252,945,000, an increase from 154,320,000asofJune30,2024,representingagrowthof63.93.7 million, significantly exceeding the related revenue, attributed to the depreciation of fixed assets and production process finalization[36] - The Company expects the high cost of goods sold to continue rising but to decrease as a percentage of revenue as production scales and efficiencies are gained[36] Financing and Capital Structure - The company issued 8,773,586 common shares and warrants pursuant to registered direct offerings, raising 13,911,000[16]−ThecompanycompletedanAt−The−Marketoffering,resultingintheissuanceof5,938,786shares,raising6,327,168[15] - The Company’s shareholders approved an increase in authorized shares from 80 million to 250 million, allowing for the reclassification of derivative liabilities totaling 2.1milliontoadditionalpaid−incapital[62]−TheCompanyhasauthorizedatotalof250,000,000sharesofcommonstockasofMarch31,2025,followinganamendmenttoincreasethenumberofauthorizedshares[93]GrantsandTaxCredits−TheCompanywasawardedataxcreditofupto40.5 million through the 48C program for a new battery recycling facility in the U.S.[56] - The Company received a grant award of 144millionfromtheU.S.DOEfortheconstructionofalithium−ionbatteryrecyclingfacility,withcumulativefundsinvoicedtotaling0.2 million as of March 31, 2025, representing 0.2% of total eligible reimbursements[57] - The Company recognized 4.3millionofinvoicedgovernmentfundsasanoffsettoresearchanddevelopmentcostsduringtheninemonthsendedMarch31,2025[50]OperationalChallengesandFutureOutlook−Thecompanyhasasignificantrelianceonobtainingdebtorequityfinancingtocontinueoperations,withsubstantialdoubtregardingitsabilitytocontinueasagoingconcernforthenext12months[25]−Thecompanyisfocusedonincreasingdomesticproductionofcriticalbatterymaterialsanddevelopingnewtechnologiesforextractionandrecyclingoflithium−ionbatteries[22]−Thecontinuationofthecompanyasagoingconcernisdependentongeneratingprofitfromoperationsandobtainingfinancing,withsubstantialdoubtexistingregardingitsabilitytocontinueforthenext12months[25]ShareholderandStockActivity−Theweightedaveragesharesoutstandingincreasedto85,090,957forthethreemonthsendedMarch31,2025,from51,993,863forthesameperiodin2024[12]−ThetotalunvestedshareawardsasofMarch31,2025,were7,816,136,withaweightedaveragegrantdatefairvalueof2.18 per unit[110] - The Company issued 14,360,308 total warrants during the nine months ended March 31, 2025, including 3,548,426 warrants from a private placement[106] Depreciation and Impairment - The Company recognized a depreciation expense of 3.8millionfortheninemonthsendedMarch31,2025,significantlyhigherthan121,075 in the previous year[21] - The Company recognized a depreciation expense of 1.2millionforthethreemonthsendedMarch31,2025,comparedto39,665 for the same period in 2024[65] - An impairment charge of $10.3 million was recorded on assets held-for-sale for the fiscal year ended June 30, 2024[67]